The estimated Net Worth of John Woock is at least 12.6 百万$ dollars as of 31 January 2024. Mr. Woock owns over 28,000 units of Axonics Inc stock worth over 6,412,646$ and over the last 6 years he sold AXNX stock worth over 6,224,314$. In addition, he makes 0$ as Chief Marketing Officer at Axonics Inc.
John has made over 19 trades of the Axonics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 28,000 units of AXNX stock worth 1,924,440$ on 31 January 2024.
The largest trade he's ever made was exercising 30,215 units of Axonics Inc stock on 17 January 2023 worth over 528,158$. On average, John trades about 12,678 units every 72 days since 2019. As of 31 January 2024 he still owns at least 93,302 units of Axonics Inc stock.
You can see the complete history of Mr. Woock stock trades at the bottom of the page.
Dr. John Woock Ph.D. serves as Chief Marketing Officer of the Company. Mr. Woock served as our VP, Global Marketing and Clinical Operations from January 2017 to May 2018 and our VP, Product Marketing from June 2014 to December 2016. Before working with our company, he was a postdoctoral fellow at the Stanford Biodesign Program at Stanford University from August 2013 to June 2014. Mr. Woock holds a B.S. in Biomedical Engineering from Washington University in St. Louis and a Ph.D. in biomedical engineering from Duke University.
John Woock is 37, he's been the Chief Marketing Officer of Axonics Inc since 2018. There are 22 older and no younger executives at Axonics Inc. The oldest executive at Axonics Inc is Nancy Snyderman, 68, who is the Independent Director.
John's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.
Over the last 6 years, insiders at Axonics Inc have traded over 108,010,643$ worth of Axonics Inc stock and bought 4,672,163 units worth 70,180,620$ . The most active insiders traders include Asset Management, Lp Chen B...、Shahzad Malik、Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of 4,280,711$. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth 2,383,374$.
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Axonics Inc executives and other stock owners filed with the SEC include: